Bejar, Andrea M
Jaramillo Gonzalez, Maria
Hong, Ziliang
Durak, Gorkem
Keles, Elif
Aktas, Halil Ertugrul
Zhang, Zheyuan
Pan, Hongyi
Jozwiak, Zeynep Sue
Bol, Fergan
Zhao, Lili
Chen, Chao
Spampinato, Concetto
Medetalibeyoglu, Alpay
Erturk, Sukru Mehmet
Kartal, Gulbiz Dagoglu
Velichko, Yury
Agarunov, Emil
Xu, Ziyue
Jambawalikar, Sachin
Schoots, Ivo G
Bruno, Marco J
Huang, Chenchang
Gonda, Tamas
Bolan, Candice
Miller, Frank H
Wallace, Michael B
Keswani, Rajesh N
Tiwari, Pallavi
Bagci, Ulas
Funding for this research was provided by:
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
National Institutes of Health (R01-CA246704)
WARF Accelerator Oncology Diagnostics Award
Article History
Received: 28 July 2025
Revised: 25 November 2025
Accepted: 31 December 2025
First Online: 12 January 2026
Declarations
:
: Authors declare no conflict of interest except the following ones: Dr. Ulas Bagci acknowledges: Ther-AI LLC.Dr. Pallavi Tiwari is an equity holder in LivAI Inc. and serves as a scientific consultant for Johnson & Johnson.Dr. Rajesh N. Keswani acknowledges: Boston Scientific - consultant; Olympus - consultant; Medtronic - consultant and research support.Dr. Michael B. Wallace acknowledges: Boston Scientific, ClearNote Health, Cosmo Pharmaceuticals, Endostart, Endiatix, Fujifilm, Medtronic, Surgical Automations, Ohelio Ltd, Venn Bioscience, Virgo Inc., Surgical Automation, and Microtek.Dr. Marco J. Bruno acknowledges: Boston Scientific - consultant, support for industry and investigator-initiated studies; Cook Medical - consultant, support for industry and investigator-initiated studies; Pentax Medical - consultant, support for investigator-initiated studies; Mylan - support for investigator initiated studies; AMBU - consultant, support for investigator initiated studies; ChiRoStim - support for investigator-initiated studies.